Tags: GILD

Overview: Gilead Sciences, Inc. (NASDAQ:GILD), from Healthcare sector has been doing well recently. Gilead Sciences, Inc. has been operating with a total market capitalizations of 95.48B and has reported a price of $73.21 today, highlighting a positive change of 0.55%. The average volume stands at 8825.3 for Gilead Sciences, Inc.. Performance: The performance week for…

Outlined as the total market value of all unsettled shares of the company, the current market cap for the Gilead Sciences, Inc. (NASDAQ:GILD) Biotechnology is valued at 92.23 B. The dominant statistics will authorize the investment community to govern the size of Gilead Sciences, Inc. compared to the sales or total assets figures. Consequently, investors will be able…

THE QUANTITATIVE RELATIONSHIPS Gilead Sciences, Inc. (GILD), started its day with an opening price of 70.72 as the company saw a change of 0.20%. The Average Volume of the business is currently 8577.22 with a P/E (price to earnings) ratio of 7.46 , while Forward P/E ratio is 9.3. The price to earnings ratio specifies…

Brief Overview Gilead Sciences, Inc. (NASDAQ:GILD), from Healthcare sector has been performing well. Gilead Sciences, Inc. reported a price of 70.29 today, indicating a change of 0.70%. Gilead Sciences, Inc. has a market capitalization of 93.02 B, with a return on assets (ROA) of 22.80% and an earnings per share (EPS) of 9.46 for the…

Brief Overview Gilead Sciences, Inc. (NASDAQ:GILD), from Healthcare sector has been performing well. Gilead Sciences, Inc. reported a price of 69.76 today, indicating a change of 0.60%. Gilead Sciences, Inc. has a market capitalization of 92.42 B, with a return on assets (ROA) of 22.80% and an earnings per share (EPS) of 9.46 for the…

With its market value over its outstanding shares, Gilead Sciences, Inc. (NASDAQ:GILD) Biotechnology has a market capitalization valued at Biotechnology. As the outstanding stock of Gilead Sciences, Inc. NASDAQ:GILD Biotechnology is bought and sold in the stock market, the current market cap indicates the existing public opinion of the net worth of Gilead Sciences, Inc. GILD Biotechnology. The existing figure surely determines…

Brief Overview Gilead Sciences, Inc. (NASDAQ:GILD), from Healthcare sector has been performing well. Gilead Sciences, Inc. reported a price of 69.7 today, indicating a change of 0.65%. Gilead Sciences, Inc. has a market capitalization of 92.29 B, with a return on assets (ROA) of 22.80% and an earnings per share (EPS) of 9.46 for the…

Outlined as the total market value of all unsettled shares of the company, the current market cap for the Gilead Sciences, Inc. (NASDAQ:GILD) Biotechnology is valued at 90.89 B. The dominant statistics will authorize the investment community to govern the size of Gilead Sciences, Inc. compared to the sales or total assets figures. Consequently, investors will be able…

Brief Overview Gilead Sciences, Inc. (NASDAQ:GILD), from Healthcare sector has been performing well. Gilead Sciences, Inc. reported a price of 70.25 today, indicating a change of -0.86%. Gilead Sciences, Inc. has a market capitalization of 92.7 B, with a return on assets (ROA) of 22.80% and an earnings per share (EPS) of 9.46 for the…

Outlined as the total market value of all unsettled shares of the company, the current market cap for the Gilead Sciences, Inc. (NASDAQ:GILD) Biotechnology is valued at 92.49 B. The dominant statistics will authorize the investment community to govern the size of Gilead Sciences, Inc. compared to the sales or total assets figures. Consequently, investors will be able…